Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Advances in recognition and treatment of social anxiety disorder: a 10-year retrospective.

Stein MB.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:97-107. Review.

PMID:
14566205
2.

An evaluation of paroxetine in generalised social anxiety disorder.

Van Ameringen M, Mancini C, Patterson B, Bennett M.

Expert Opin Pharmacother. 2005 May;6(5):819-30. Review.

PMID:
15934907
3.

Update on the diagnosis and treatment of social anxiety disorder.

Liebowitz MR.

J Clin Psychiatry. 1999;60 Suppl 18:22-6. Review.

4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

The nature of social anxiety disorder.

Westenberg HG.

J Clin Psychiatry. 1998;59 Suppl 17:20-6. Review.

PMID:
9811426
6.

How is recovery from social anxiety disorder defined?

Bobes J.

J Clin Psychiatry. 1998;59 Suppl 17:12-9. Review.

PMID:
9811425
7.

[Neurobiology and pharmacotherapy of social phobia].

Aouizerate B, Martin-Guehl C, Tignol J.

Encephale. 2004 Jul-Aug;30(4):301-13. Review. French.

PMID:
15538306
8.

Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.

Pollack MH.

J Clin Psychiatry. 2001;62 Suppl 12:24-9. Review.

9.
10.

An epidemiologic perspective on social anxiety disorder.

Stein MB.

J Clin Psychiatry. 2006;67 Suppl 12:3-8. Review.

11.

The many faces of social anxiety disorder.

Wittchen HU.

Int Clin Psychopharmacol. 2000 Jul;15 Suppl 1:S7-12. Review.

PMID:
10994677
12.

Comorbidity in social anxiety disorder: impact on disease burden and management.

Lecrubier Y.

J Clin Psychiatry. 1998;59 Suppl 17:33-8. Review.

PMID:
9811428
13.
14.

Paroxetine in the treatment of generalised anxiety disorder.

Snyderman SH, Rynn MA, Bellew K, Rickels K.

Expert Opin Pharmacother. 2004 Aug;5(8):1799-806. Review.

PMID:
15264994
15.

Social anxiety disorder: etiology and early clinical presentation.

Beidel DC.

J Clin Psychiatry. 1998;59 Suppl 17:27-32. Review.

PMID:
9811427
16.

Pharmacotherapy for social anxiety disorder: an update.

Van Ameringen M, Mancini C, Patterson B, Simpson W.

Isr J Psychiatry Relat Sci. 2009;46(1):53-61. Review.

17.

[Treatment-resistant anxiety disorders: social phobia, generalized anxiety disorder and panic disorder].

Menezes GB, Fontenelle LF, Mululo S, Versiani M.

Rev Bras Psiquiatr. 2007 Oct;29 Suppl 2:S55-60. Review. Portuguese.

18.

Efficacy and tolerability of controlled-release paroxetine.

Golden RN.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:176-86. Review.

PMID:
14566210
19.

Defining an appropriate management strategy for social anxiety disorder.

Davidson JR.

Int Clin Psychopharmacol. 2000 Jul;15 Suppl 1:S13-7. Review.

PMID:
10994678
20.

Supplemental Content

Support Center